10 January 2017 - Deborah Wilkes
Archived
Mylan is acquiring global rights to the Cold-EEZE OTC brand from ProPhase Labs in a deal worth USD50 million. The generics giant intends to continue boosting its global OTC presence through further product acquisitions.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.